Emcure Pharmaceuticals Ltd.
EMCURE
Clasificación en acciones
#4336
Emcure Pharmaceuticals Limited is committed to providing high-quality,... Emcure Pharmaceuticals Limited is committed to providing high-quality, cost-effective healthcare solutions to a global market. The company boasts a diverse product lineup spanning numerous medical fields, such as women's health (gynecology), anti-infectives, pain relief, nutritional supplements (vitamins, minerals, and nutrients), hematology, oncology, respiratory treatments, HIV antivirals, gastrointestinal remedies, anti-diabetics, neurological medications, and cardiovascular therapies. Notable brand names under their umbrella include Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym. Founded in 1981, Emcure Pharmaceuticals Limited is headquartered in Pune, India.
Precio por acción
$18.85
Capitalización bursátil
$3.58B
Cambio (1 día)
-2.91%
Cambio (1 año)
19.17%
País
IN
Comercio Emcure Pharmaceuticals Ltd. (EMCURE)
Categoría
Healthcare
Ratio P/B de Emcure Pharmaceuticals Ltd. (EMCURE)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Emcure Pharmaceuticals Ltd., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Emcure Pharmaceuticals Ltd. desde 2026 hasta 2026
Ratio P/B al final de cada año
| Año | Ratio P/B | Cambiar |
|---|---|---|
| Not enough data for the provided dates. | ||
Ratio P/B de empresas similares o competidoras
| Empresa | Ratio P/B | Diferencia del ratio P/B | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | - |
IN
|
